This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Gregory Stein: Innovator in Cystathionine-γ-Lyase Inhibitors
Introduction
Gregory Stein is an accomplished inventor based in the United States. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of cystathionine-γ-lyase (CSE) inhibitors. Although he currently holds no patents, his work has the potential to impact various medical treatments.
Latest Patents
Stein's latest patents focus on compounds and pharmaceutical compositions that inhibit cystathionine-γ-lyase (CSE). These compounds are designed to treat diseases or conditions that would benefit from CSE inhibition. The patents describe methods for using these inhibitors, either alone or in combination with other compounds, to enhance therapeutic outcomes.
Career Highlights
Throughout his career, Gregory Stein has worked with notable companies such as Sova Pharmaceuticals, Inc. and Bristol-Myers Squibb Company. His experience in these organizations has allowed him to develop his expertise in pharmaceutical innovation and research.
Collaborations
Stein has collaborated with several professionals in his field, including Sergio G. Duron and Justin Chapman. These partnerships have contributed to his research and development efforts in the pharmaceutical industry.
Conclusion
Gregory Stein's work in developing cystathionine-γ-lyase inhibitors showcases his commitment to advancing medical science. His contributions, although not yet patented, hold promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile